The current COCP market cap is 15.46M. The company's latest EPS is USD -3.8174 and P/E is -0.39.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 1.6M |
Operating Income | 13.4M | -4.5M | -5.11M | -4.34M | -4.44M |
Net Income | -5.7M | -4.5M | -5.19M | -4.17M | -4.17M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 6.56M | 2.01M | 0 | 0 |
Operating Income | -62.92M | -48.41M | -9.59M | -14.22M | -19.74M |
Net Income | -49.05M | -48.17M | -9.65M | -14.19M | -38.84M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 45.65M | 40.84M | 37.84M | 36.28M | 32.61M |
Total Liabilities | 1.74M | 1.27M | 3.17M | 1.6M | 1.92M |
Total Equity | 43.91M | 39.57M | 34.67M | 34.68M | 30.69M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 68.56M | 28.53M | 54.24M | 79.39M | 40.84M |
Total Liabilities | 1.67M | 2.82M | 1.74M | 1.84M | 1.27M |
Total Equity | 66.89M | 25.71M | 52.51M | 77.55M | 39.57M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -16.54M | -21.44M | -3.11M | -8.66M | -11.34M |
Investing | -62k | -74k | -45k | -59k | -59k |
Financing | -20k | -27k | -7k | 3.99M | 3.99M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -8.29M | -1.56M | -9.83M | -12.72M | -21.44M |
Investing | 1.37M | -145k | -240k | -52k | -74k |
Financing | 8.89M | 6.42M | 35.66M | 38.47M | -27k |
Market Cap | 15.46M |
Price to Earnings Ratio | -0.39 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.41 |
Price to Book Ratio | 0.38 |
Dividend Yield | - |
Shares Outstanding | 10.17M |
Average Volume (1 week) | 12.91k |
Average Volume (1 Month) | 13.32k |
52 Week Change | -18.72% |
52 Week High | 3.285 |
52 Week Low | 1.325 |
Spread (Intraday) | 0.14 (9.21%) |
Company Name | Cocrystal Pharma Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.cocrystalpharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.